[Healthcare Payer News] Sovaldi spurs call to action on high drug costs
May 21, 2014
By Anthony Brino May 21, 2014 The breakthrough hepatitis drug Sovaldi… Read More
© 2025 CSRXP- All Rights Reserved
News & Highlights
[Politico] No consensus on how to afford specialty drugs
May 21, 2014
By Brett Norman May 21, 2014 The astronomical price of a new “miracle”… Read More
[Inside Health Policy] Spurred By Sovaldi’s Price, Drug Makers & Plans Consider Mortgaging Pricey Drugs
May 21, 2014
By John Wilkerson May 21, 2014 Spurred by the prospect of Sovaldi’s… Read More
[Roanoke Times] The People’s Pharmacy: Will cost of cancer drugs break the bank?
May 20, 2014
By Joe and Teresa Graedon May 20, 2014 Cancer has become a cash cow for… Read More
[McClatchy DC] Insurers, regulators prepare to negotiate 2015 health coverage costs
May 20, 2014
By Tony Pugh May 20, 2014 The risk pools in these 24 states need these healthy… Read More
[California Health Line] High-Priced Drug Could Be Deal Changer
May 19, 2014
By George Lauer May 19, 2014 An effective, high-priced drug has… Read More
[Puget Sound Business Journal] $1,000-a-pill hepatitis C drug may be too costly for Medicaid insurers
May 14, 2014
By Atia Musazay May 14, 2014 A breakthrough drug now on the market… Read More
[Bloomberg Government] Backlash on Rising Drug Prices Led by Cancer Doctors, Insurers
May 7, 2014
By Robert Langreth May 7, 2014 The backlash over surging drug… Read More
[Georgia Health News] Hepatitis C: The high cost of a cure
May 6, 2014
By Andy Miller May 6, 2014 Probably the biggest ethical dilemma now… Read More
[Forbes] At $1,000 A Pill, Hepatitis C Drug Sovaldi Rattles Medicaid Programs
Apr 28, 2014
By Bruce Jaspen April 28, 2014 Medicaid health insurance programs for… Read More
[Washington Post] An $84,000 hepatitis drug is giving states and insurers a major headache
Apr 28, 2014
By Jason Millman April 28, 2014 The new hepatitis C drug Sovaldi is… Read More
[The New Yorker] BIOTECH’S HARD BARGAIN
Apr 28, 2014
BY JAMES SUROWIECKI April 28 Issue Few people have done better in the… Read More